Systemic Immune Deficiency Necessary for Cytomegalovirus Invasion of the Mature Brain

Journal of Virology

Volumn 78, Issue 3, 2004, Pages 1473-1487

  Reuter, Jon D ^a   Gomez, Daniel L ^a   Wilson, Jean H ^a   Van Den Pol, Anthony N ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; GREEN FLUORESCENT PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; BRAIN MATURATION; BRAIN NECROSIS; CENTRAL NERVOUS SYSTEM INFECTION; CHOROIDITIS; COGNITIVE DEFECT; CONTROLLED STUDY; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; ENCEPHALITIS; EPENDYMA CELL; FATALITY; FEMALE; GLIA CELL; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INOCULATION; MENINX; MENTAL DISEASE; MONONUCLEAR CELL; MOUSE; NERVE FIBER TRANSPORT; NEUROLOGIC DISEASE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; REPORTER GENE; SCID MOUSE; T LYMPHOCYTE; VASCULITIS; VIRUS RECOMBINANT; VIRUS RESISTANCE; VIRUS TRANSMISSION;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; ENCEPHALITIS; FEMALE; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HERPESVIRIDAE INFECTIONS; IMMUNOLOGIC DEFICIENCY SYNDROMES; LEUKOCYTES, MONONUCLEAR; LUMINESCENT PROTEINS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICE, SCID; MONOCYTES; MUROMEGALOVIRUS; RECOMBINANT PROTEINS; RISK FACTORS; VIREMIA;

EID: 0347634396     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.3.1473-1487.2004     Document Type: Article

References (54)

1. Alford, C.A., and W. J. Britt. 1996. Cytomegalovirus, p. 2493-2534. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology. Lippincott-Raven, Philadelphia, Pa.
2. Anduze-Faris, B. M., A.-M. Fillet, J. Gozlan, R. Lancar, N. Bouldi, J. Gasnault, E. Caumes, J. Livartowsky, S. Matheron, C. Leport, D. Salmon, D. Costagliola, and C. Katlama. 2000. Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients. AIDS 14:517-524.
3. Arribas, J. R., D. B. Clifford, C. J. Fichtenbaum, D. L. Commins, W. G. Powderly, and G. A. Storch. 1995. Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system. J. Infect. Dis. 172:527-531.
4. Baskin, G.B. 1987. Disseminated cytomegalovirus infection in immunodeficient rhesus monkeys. Am. J. Pathol. 129:345-352.
5. Bélec, L., F. Gray, J. Mikol, F. Scaravilli, C. Mhiri, A. Sobel, and J. Poirier. 1990. Cytomegalovirus (CMV) encephalomyeloradiculitis and human immunodeficiency virus (HIV) encephalitis: presence of HIV and CMV co-infected multinucleated giant cells. Acta Neuropathol. 81:99-104.
6. Bevan, I. S., C. C. Sammons, and C. Sweet. 1996. Investigation of murine cytomegalovirus latency and reactivation in mice using viral mutants and the polymerase chain reaction. J. Med. Virol. 48:308-320.
7. Booss, J., S. R. Winkler, B. P. Griffith, and J. H. Kim. 1989. Viremia and glial nodule encephalitis after experimental systemic cytomegalovirus infection. Lab. Investig. 61:644-649.
8. Booss, J., P. R. Dann, B. P. Griffith, and J. H. Kim. 1989. Host defense response to cytomegalovirus in the central nervous system. Predominance of the monocyte. Am. J. Pathol. 134:71-78.
9. Borucki, M., and R. B. Pollard. 1994. Cytomegalovirus diseases, p. 323-338. In R. R. McKendall and W. G. Stroop (ed.), Handbook of neurovirology. Marcel Dekker, New York, N.Y.
10. Bosma, G. C., R. P. Custer, and M. J. Bosma. 1983. A severe combined immunodeficiency mutation in the mouse. Nature 301:527-530.
11. Broadwell, R. D., and M. W. Brightman. 1976. Entry of peroxidase into neurons of the central and peripheral nervous systems from extracerebral and cerebral blood. J. Comp. Neurol. 166:257-283.
12. Bruggeman, C. A., F. Li, and F. S. Stals. 1995. Pathogenicity: animal models. Scand. J. Infect. Dis. Suppl. 99:43-50.
13. Chang, W. L. W., A. F. Tarantal, S. S. Zhou, A. D. Borowsky, and P. A. Barry. 2002. A recombinant rhesus cytomegalovirus expressing enhanced green fluorescent protein retains the wild-type phenotype and pathogenicity in fetal macaques. J. Virol. 76:9493-9504.
14. Chimelli, L., S. Rosemberg, M. D. Hahn, M. B. Lopes, and M. B. Netto. 1992. Pathology of the central nervous system in patients infected with the human immunodeficiency virus (HIV): a report of 252 autopsy cases from Brazil. Neuropathol. Appl. Neurobiol. 18:477-488.
15. Collins, T., C. Pomeroy, and M. C. Jordan. 1993. Detection of latent cytomegalovirus DNA in diverse organs of mice. J. Infect. Dis. 168:725-729.
16. Fernandez, J. A., E. G. Rodrigues, and M. Tsuji. 2000. Multifactorial protective mechanisms to limit viral replication in the lung of mice during primary murine cytomegalovirus infection. Viral Immunol. 13:287-295.
17. Griffith, B. P., H. L. Lucia, and G. D. Hsiung. 1982. Brain and visceral involvement during congenital cytomegalovirus infection of guinea pigs. Pediatr. Res. 16:455-459.
18. Gupta, P., J. Hart, D. Cronin, S. Kelly, J. M. Millis, and L. Brady. 2001. Risk factors for chronic rejection after pediatric liver transplantation. Transplantation 72:1098-1102.
19. Harrison, M. J. G., and J. C. McArthur. 1995. AIDS and neurology, p. 92. Churchill Livingstone, New York, N.Y.
20. Harrison, M. J. G., and J. C. McArthur. 1995. AIDS and neurology, p. 136-141. Churchill Livingstone, New York, N.Y.
21. Johnson, R. T. 1998. Viral infections of the nervous system, 2nd ed. Lippincott-Raven, Philadelphia, Pa.
22. Kercher, L., and B. M. Mitchell. 2000. Immune transfer protects severely immunosuppressed mice from murine cytomegalovirus retinitis and reduces the viral load in ocular tissue. J. Infect. Dis. 182:653-661.
23. Koffron, A. J., M. Hummel, B. K. Patterson, S. Yan, D. B. Kaufman, J. P. Fryer, F. P. Stuart, and M. 1. Abecassis. 1998. Cellular localization of latent murine cytomegalovirus. J. Virol. 72:95-103.
24. Kosugi, I., Y. Shinmura, H. Kawasaki, Y. Arai, R.-Y. Li, S. Baba, and Y. Tsutsui. 2000. Cytomegalovirus infection of the central nervous system stem cells from mouse embryo: a model for developmental brain disorders induced by cytomegalovirus. Lab. Investig. 80:1373-1383.
25. Kroger, N., T. Zabelina, W. Kruger, H. Renges, N. Stute, J. Schrum, H. Kabisch, P. Schafhausen, N. Jaburg, C. Loliger, P. Schafer, A. Hinke, and A. R. Zander. 2001. Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion with anti-thymocyte globulin. Br. J. Haematol. 113:1060-1071.
26. McCutchan, J. A. 1995. Clinical aspect of cytomegalovirus infections of the nervous system in patients with AIDS. Clin. Infect. Dis. Suppl. 2: S196-S201.
27. Medearis, D. N., and S. L. Prokay. 1978. Effect of immunization of mothers on cytomegalovirus infection in suckling mice. Proc. Soc. Exp. Biol. Med. 157:523-527.
28. Melnick, J. L., C. Hu, J. Burkek, E. Adam, and M. E. DeBakey. 1994. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J. Med. Virol. 42:170-174.
29. Mercer, J. A., C. A. Wiley, and D. H. Spector. 1988. Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infections. J. Virol. 62:987-997.
30. Minton, E. J., C. Tysoe, J. H. Sinclair, and J. G. P. Sissons. 1994. Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J. Virol. 68:4017-4021.
31. Mocarski, E. 1996. Cytomegaloviruses and their replication, p. 2447-2492. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology. Lippincott-Raven, Philadelphia, Pa.
32. Myerson, D., R. C. Hackman, J. A. Nelson, D. C. Ward, and J. K. McDougall. 1984. Widespread presence of histologically occult cytomegalovirus. Hum. Pathol. 15:430-439.
33. Navia, B. A., E. S. Cho, C. K. Petito, and R. W. Price. 1996. The AIDS dementia complex 11. Neuropathology. Ann. Neurol. 19:525-535.
34. Nelson, J. A., C. Reynolds-Kohler, M. B. A. Oldstone, and C. A. Wiley. 1988. HIV and HCMV coinfect brain cells in patients with AIDS. Virology 165: 286-290.
35. Osborn, J. E. 1982. Cytomegalovirus and other herpeseviruses, p. 267-292. In H. Foster, D. Small, and J. Fox (ed.), The mouse in biomedical research, vol. II. Academic Press, Inc., New York, N.Y.
36. Reynolds, R. P., R. J. Rahija, D. I. Schenkman, and C. B. Richter. 1993. Experimental murine cytomegalovirus infection in severe combined immunodeficient mice. Lab. Anim. Sci. 43:291-295.
37. Scholz, M., R. A. Blaheta, J.-U. Vogel, H. W. Doerr, and J. Cinatl, Jr. 1999. Cytomegalovirus-induced transendothelial cell migration. Intervirology 42: 350-356.
38. Seo, S. K., A. Regan, T. Cihlar, D. C. Lin, F. Boulad, D. George, V. K. Prasad, T. E. Kiehn, and B. Polsky. 2001. Cytomegalovirus ventriculoencephalitis in a bone marrow transplant recipient receiving antiviral maintenance: clinical and molecular evidence of drug resistance. Clin. Infect. Dis. 33:e105-e108.
39. Setinek, U., E. Wondrusch, K. Jellinger, A. Steuer, M. Drlicek, W. Grisold, and F. Lintner. 1995. Cytomegalovirus infection of the brain in AIDS: a clinicopathological study. Acta Neuropathol. 90:511-515.
40. Spitzer, P. G., D. Tarsy, and G. M. Eliopoulos. 1987. Acute transverse myelitis during disseminated cytomegalovirus infection in a renal transplant recipient. Transplantation 44:151-153.
41. Starr, S. E., and A. C. Allison. 1977. Role of T lymphocytes in recovery from murine cytomegalovirus infection. Infect. Immun. 17:458-462.
42. Stroop, W. G. 1994. Viral pathogenesis. p. 27-54. In R. R. McKcndall and W. G. Stroop (ed.), Handbook of neurovirology. Marcel Dekker, New York, N.Y.
43. Trgovcich, J., D. Stimac, B. Polic, A. Krmpotic, E. Pernjak-Pugel, J. Tomac, M. Hasan, B. Wraber, and S. Jonjic. 2000. Immune responses and cytokine induction in the development of severe hepatitis during acute infections with murine cytomegalovirus. Arch. Virol. 145:2601-2618.
44. Tsutsui, Y., A. Kashiwai, N. Kawamura, S. Aiba-Masago, and I. Kosugi. 1995. Prolonged infection of mouse brain neurons with murine cytomegalovirus after pre- and perinatal infection. Arch. Virol. 140:1725-1736.
45. van den Pol, A., E. Mocarski, N. Saederup, J. Vierira, and T. J. Meier. 1999. Cytomegalovirus cell tropism, replication, and gene transfer in brain. J. Neurosci. 19:10948-10965.
46. van den Pol, A. N., J. Vieira, D. D. Spencer, and J. G. Santarelli. 2000. Mouse cytomegalovirus in developing brain tissue: analysis of 11 species with GFP-expressing recombinant virus. J. Comp. Neurol. 427:559-580.
47. van den Pol, A. N., J. D. Reuter, and J. G. Santarelli. 2002. Enhanced cytomegalovirus infection of developing brain independent of the adaptive immune system. J. Virol. 76:8842-8854.
48. van der Bij, W., and R. Speich. 2001. Management of cytomegalovirus infection and disease after solid-organ transplantation. Clin. Infect. Dis. 33(Suppl. 1):S32-S37.
49. Vinters, H. V., M. K. Kwok, H. W. Ho, K. H. Anders, U. Tomiyasu, W. L. Wolfson, and F. Robert. 1989. Cytomegalovirus in the nervous system of patients with the acquired immune deficiency syndrome. Brain 112:245-268.
50. Vogel, J.-U., M. Scholz, and J. Cinatl. 1997. Treatment of cytomegalovirus disease. Intervirology 40:357-367.
51. Wiley, C. A., R. D. Schrier, F. J. Denaro, J. A. Nelson, P. W. Lampert, and M. B. A Oldstone. 1986. Localization of cytomegalovirus proteins and genome during fulminant central nervous system infection in AIDS patient. J. Neuropathol. Exp. Neurol. 45:127-139.
52. Wiley, C. A., and J. A. Nelson. 1998. Role of human immunodeficiency virus and cytomegalovirus in AIDS encephalitis. Am. J. Pathol. 133:73-81.
53. Yuh, W. T., H. D. Nguyen, F. Gao, E. T. Tali, D. J. Fisher, N. A. Mayr, D. P. Mueller, Y. Sato, M. E. Trigg, and R. Gingrich. 1994. Brain parenchymal infection in bone marrow transplantation patients: CT and MR findings. Am. J. Roentgenol. 162:425-430.
54. Zemanick, M. C., P. L. Strick, and R. D. Dix. 1991. Direction of transneuronal transport of herpes simplex virus I in the primate motor system is strain-dependent. Proc. Natl. Acad. Sci. USA 88:8048-8051.